摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Δ1(6)-2,5-oxathiabicyclo<4.3.0>nonene | 35676-59-6

中文名称
——
中文别名
——
英文名称
Δ1(6)-2,5-oxathiabicyclo<4.3.0>nonene
英文别名
3,5,6,7-tetrahydro-2H-cyclopenta[b][1,4]oxathiine
Δ<sup>1(6)</sup>-2,5-oxathiabicyclo<4.3.0>nonene化学式
CAS
35676-59-6
化学式
C7H10OS
mdl
——
分子量
142.222
InChiKey
BRLZIXYKXFHKQP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    101-107 °C(Press: 6 Torr)
  • 密度:
    1.18±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    34.5
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    2,2-dimethoxycyclopentanol2-巯基乙醇对甲苯磺酸 作用下, 以 为溶剂, 反应 3.0h, 以89%的产率得到Δ1(6)-2,5-oxathiabicyclo<4.3.0>nonene
    参考文献:
    名称:
    Fjeldskaar, Inger Reidun; Rongved, Paul; Skatteboel, Lars, Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry, 1987, vol. 41, # 7, p. 477 - 486
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • ACRYLATE ESTER DERIVATIVES AND POLYMER COMPOUNDS
    申请人:NAKAYAMA Osamu
    公开号:US20120316349A1
    公开(公告)日:2012-12-13
    A cyclic alcohol of formula (II-1): wherein: R 2 , R 3 , and R 4 are each independently a hydrogen atom, a linear alkyl group comprising 1 to 6 carbon atoms, a branched alkyl group comprising 3 to 6 carbon atoms, or a cyclic alkyl group comprising 3 to 6 carbon atoms; or R 2 and R 3 or R 3 and R 4 combine to form an alkylene group comprising 3 to 6 carbon atoms; m is 1 or 2; R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 are each independently a hydrogen atom, a linear alkyl group comprising 1 to 6 carbon atoms, a branched alkyl group comprising 3 to 6 carbon atoms, or a cyclic alkyl group comprising 3 to 6 carbon atoms; A is an oxygen atom; and B is an oxygen atom or a sulfur atom. In addition, a process for producing the cyclic alcohol of formula (II-1).
    一种化学式为(II-1)的环状醇:其中:R2、R3和R4分别独立地是氢原子、由1至6个碳原子组成的直链烷基基团、由3至6个碳原子组成的支链烷基基团或由3至6个碳原子组成的环状烷基基团;或者R2和R3或R3和R4结合形成由3至6个碳原子组成的亚烯基基团;m为1或2;R5、R6、R7、R8、R9和R10分别独立地是氢原子、由1至6个碳原子组成的直链烷基基团、由3至6个碳原子组成的支链烷基基团或由3至6个碳原子组成的环状烷基基团;A为氧原子;B为氧原子或原子。此外,一种制备化学式(II-1)的环状醇的方法。
  • RAMAZANOV, EH. A.;KERIMOV, F. F.;MURSAKULOV, I. G.;ASLANOVA, M. R.;TAIROV+, AZERB. XIM. ZH.,(1987) N 4, 79-80
    作者:RAMAZANOV, EH. A.、KERIMOV, F. F.、MURSAKULOV, I. G.、ASLANOVA, M. R.、TAIROV+
    DOI:——
    日期:——
  • FJELDSKAAR, INGER REIDUN;RONGVED, RAUL;SKATTEVZHUSTOL, LARS, ACTA CHEM. SCAND., 41,(1987) N 7, 474-486
    作者:FJELDSKAAR, INGER REIDUN、RONGVED, RAUL、SKATTEVZHUSTOL, LARS
    DOI:——
    日期:——
  • US8431722B2
    申请人:——
    公开号:US8431722B2
    公开(公告)日:2013-04-30
  • US8362169B2
    申请人:——
    公开号:US8362169B2
    公开(公告)日:2013-01-29
查看更多

同类化合物

6-乙氧基-2-甲基-5,6-二氢-1,4-氧硫杂环己二烯-3-羧酸 5,6-二氢-1,4-氧硫杂环己二烯-2-羧酸 5,6,7,8-四氢-4,7-二甲基-1,2-苯并氧硫杂环己二烯 2,2-二氧化物 2-甲基-5,6-二氢-1,4-氧硫杂环己二烯-3-甲酸 2-甲基-1,4-氧硫杂环己二烯-3-羧酸 1-(6-乙氧基-2-甲基-4-氧代-5,6-二氢-1,4-氧硫杂环己二烯-3-基)乙酮 1,4-苯并氧硫杂环己二烯4,4-二氧化物 1,4-氧硫杂环己二烯 1,4-噁噻英,2,3-二氢-5,6-二甲基- 1,2-苯并噁噻英,3,4-二氢- 1,2-氧硫杂环己二烯 5,6-dihydro-[1,4]oxathiine-2,3-dicarboxylic acid dimethyl ester (6-[1,3]Dithian-2-ylmethyl-benzo[1,3]dioxol-5-yl)-carbamic acid tert-butyl ester 2,6-dimethyl-4-(1,1,3,3-tetraoxo-1λ6,3λ6-[1,3]dithietan-2-ylidene)-4H-pyran Pyrrolidine,1-(3-chloro-3,4,5,6,7,8-hexahydro-2,2-dioxido-1,2-benzoxathiin-4-yl)-,trans- β-Methyl-β-dimethylamino-pent-3-en-sulfonsaeure-sulton (2,2-Dioxo-6-phenyl-3,4-dihydro-2H-2λ6-[1,2]oxathiin-4-yl)-diethyl-amine 6,12,18,24,25,27,29,31-octachloro-2,8,14,20-tetraoxa-3λ6,9λ6,15λ6,21λ6-tetrathiapentacyclo[20.2.2.24,7.210,13.216,19]dotriaconta-1(25),4(32),5,7(31),10(30),11,13(29),16(28),17,19(27),22(26),23-dodecaene 3,3,9,9,15,15,21,21-octaoxide O-methyl-(5,6-dihydro-2-methyl-1,4-oxathiin-3-yl)carbonyl carbamothioate 6-tert-Butyl-N,N,2-trimethyl-4-oxo-4H-3,1-benzoxathiin-8-carboxamid-1-oxid Dimethyl-(4-methyl-2,2-dioxo-3,6-dihydro-2H-2λ6-[1,2]oxathiin-5-yl)-amine (2S,6S)-2,6-Diethyl-4-ethylsulfanyl-5-methyl-6H-[1,3]oxathiine 5,6-dihydro-2-methyl-1,4-oxathiin-3-carboxylic acid hydrazide 18-methoxy-5,8,11-trioxa-2,14-dithia-18-azabicyclo[13.2.1]octadeca-1(17),15-diene 9',10'-dihydrospiro[cyclohexane-1,11'-[9,10](epithiooxymethano)anthracene] 13',13'-dioxide 6-(Morpholin-4-methyl)-2-(4-morpholinyl)-1,4,3-oxathiazin-4,4-dioxid 3-Methoxy-1,8,8-trioxo-2-oxa-8λ6-thia-spiro[4.5]deca-6,9-diene-3-carboxylic acid methyl ester 41,42-dimethoxy-5,8,11,14,25,28,31,34-octaoxa-2,17,22,37-tetrathia-41,42-diazatricyclo[36.2.1.118,21]dotetraconta-1(40),18,20,38-tetraene 35,36-dimethoxy-5,8,11,22,25,28-hexaoxa-2,14,19,31-tetrathia-35,36-diazatricyclo[30.2.1.115,18]hexatriaconta-1(34),15,17,32-tetraene 2,2-dimethyl-4-phenyl-6,6-bis-trifluoromethyl-6H-[1,3,5]oxathiazine 3-(1,1,2,2,3,3-hexafluoropropyl)-4-thia-2-hexen-6-olide 21-methoxy-5,8,11,14-tetraoxa-2,17-dithia-21-azabicyclo[16.2.1]henicosa-1(20),18-diene 3-bromo-4,6-diphenyl-[1,2]-oxathiine 2,2-dioxide (Z)-7,8-Dihydro-4H-1,3-oxathiocin-2-one (E)-4-Methyl-7,8,9,10-tetrahydro-4H-[1,3]oxathiecin-2-one 1-(2,2-Dioxo-3,4,7,8-tetrahydro-2H,5H-2λ6-thiopyrano[3,4-e][1,2]oxathiin-4-yl)-piperidine 1-(2,2-Dioxo-3,4,5,6-tetrahydro-2H-2λ6-thieno[3',2':3,4]benzo[1,2-e][1,2]oxathiin-4-yl)-piperidine 24-methoxy-5,8,11,14,17-pentaoxa-2,20-dithia-24-azabicyclo[19.2.1]tetracosa-1(23),21-diene 47,48-dimethoxy-5,8,11,14,17,28,31,34,37,40-decaoxa-2,20,25,43-tetrathia-47,48-diazatricyclo[42.2.1.121,24]octatetraconta-1(46),21,23,44-tetraene 5-Isopropyl-2,3-dihydro-[1,4]oxathiine 1-(2,2-Dioxo-3,4,5,6-tetrahydro-2H-2λ6-thieno[3',2':3,4]benzo[1,2-e][1,2]oxathiin-4-yl)-pyrrolidine (5,6-dihydro-1,4-oxathiin-3-yl)acetic acid 2-(2-Methyl-allyl)-1-(2-methyl-5,6-dihydro-[1,4]oxathiine-3-carbonyl)-isothiourea 6-ethoxy-5,6-dihydro-2-methyl-1,4-oxathiin-3-carbonyl chloride 6-Cyclopropyl-2,3-dihydro-1,4-oxathiine-5-carboxylic acid 2-Methyl-6-(trifluoromethyl)-2,3-dihydro-1,4-oxathiine-5-carboxylic acid 3-Methyl-6-(trifluoromethyl)-2,3-dihydro-1,4-oxathiine-5-carboxylic acid 3,4,6-trimethyl-[1,2]oxathiin-2,2-dioxide 2-Methyl-4-heptyl-butadien-(1.3)-sulton-(1.4)